Tamoxifen affects PLCg1 expression in ER plus breast cancer cells

被引：0
|
作者：
Vergne, Ralphdy [1 ]
Ortiz, Carmen [2 ]
Godoy, Lenin [2 ]
Matta, Jaime [2 ]
机构：
[1] Univ Puerto Rico Ponce, Biol, Ponce, PR USA
[2] Ponce Hlth Sci Univ, Basic Sci, Ponce, PR USA
来源：
FASEB JOURNAL | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
936.2
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Increasing DAXX Expression in ER plus Breast Cancer Cells to Overcome Endocrine Therapy Resistance
    Osipo, Clodia
    Albain, Kathy S.
    Peiffer, Daniel
    Wyatt, Debra
    CANCER RESEARCH, 2023, 83 (05)
  • [32] Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen
    Yin, Li
    Pan, Xiaohua
    Zhang, Xin-Tian
    Guo, Yu-Ming
    Wang, Zhao-Yi
    Gong, Yaoqin
    Wang, Molin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (02): : 530 - U469
  • [33] ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER plus breast cancer
    Heckler, Mary M.
    Thakor, Hemang
    Schafer, Cara C.
    Riggins, Rebecca B.
    FEBS JOURNAL, 2014, 281 (10) : 2431 - 2442
  • [34] The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio
    Gabriel Pons, Daniel
    Nadal-Serrano, Mercedes
    Torrens-Mas, Margalida
    Oliver, Jordi
    Roca, Pilar
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (01) : 218 - 229
  • [35] Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells
    Banerjee, Shreya
    Kambhampati, Suman
    Banerjee, Sushanta K.
    Haque, Inamul
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2011, 5 (04) : 317 - 324
  • [36] Effects of Jaeumkanghwa-tang on tamoxifen responsiveness in preclinical ER plus breast cancer model
    Andrade, Fabia De Oliveira
    Yu, Wei
    Zhang, Xiyuan
    Carney, Elissa
    Hu, Rong
    Clarke, Robert
    FitzGerald, Kevin
    Hilakivi-Clarke, Leena
    ENDOCRINE-RELATED CANCER, 2019, 26 (03) : 339 - 353
  • [37] Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells
    Shreya Banerjee
    Suman Kambhampati
    Inamul Haque
    Sushanta K. Banerjee
    Journal of Cell Communication and Signaling, 2011, 5 : 317 - 324
  • [38] Estrogen receptor inhibition with tamoxifen mediates radiosensitization of ER plus breast cancer models.
    Michmerhuizen, Anna R.
    Pesch, Andrea M.
    Schwartz, Rachel
    Wilder-Romans, Kari
    Liu, Meilan
    Azaria, Ruth
    Jelley, Alexa
    Pierce, Lori J.
    Speers, Corey W.
    CANCER RESEARCH, 2021, 81 (13)
  • [39] Reversal of tamoxifen resistance by artemisinin in ER plus breast cancer: bioinformatics analysis and experimental validation
    Zhuo, Zhili
    Zhang, Dongni
    Lu, Wenping
    Wu, Xiaoqing
    Cui, Yongjia
    Zhang, Weixuan
    Zhang, Mengfan
    ONCOLOGY RESEARCH, 2024, 32 (06) : 1093 - 1107
  • [40] Cyclin D1 predicts tamoxifen benefit in women with early stage ER plus breast cancer.
    Koh, J
    Burch, P
    Godin, K
    Beatty, B
    Pinet, M
    Bunn, JY
    Tam, D
    Simmons-Arnold, L
    Weaver, D
    Muss, HB
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 246 - 246
12345